New glycolipid compounds, process for preparation and use as immunological adjuvant
申请人:Merck & Co., Inc.
公开号:EP0023865A2
公开(公告)日:1981-02-11
Compounds of the formulae Y-R wherein Y is 1-thio-B-L-fucose, 1-thio-B-D-galactose or 1-thio-B-lactose and R is 2-(1- adamantyl) ethyt, 3- [(p-tetrafluorophenethyl) phenyl] propyl, 6-(5-cholesten-3B-yloxy) hex-3-ynl, oleyl, or hexadecyl are useful immunologic adjuvants in vaccines.
Y-R 式中 Y 为 1-硫代-B-L-岩藻糖、1-硫代-B-D-半乳糖或 1-硫代-B-乳糖,R 为 2-(1-金刚烷基)乙基、3-[(对氟苯乙基)苯基]丙基、6-(5-胆甾烯-3B-氧基)己-3-炔基、油基或十六烷基的化合物是疫苗中有用的免疫佐剂。
US4259324A
申请人:——
公开号:US4259324A
公开(公告)日:1981-03-31
Immunologic adjuvant thio glycoside compounds and compositions
申请人:Merck & Co., Inc.
公开号:US04259324A1
公开(公告)日:1981-03-31
Compounds of the formulae Y--R wherein Y is 1-thio-.beta.-L-fucose, 1-thio-.beta.-D-galactose or 1-thio-.beta.-lactose and R is 2-(1-adamantyl)ethyl, 3-[(p-tetrafluorophenethyl)phenyl]propyl, 6-(5-cholesten-3.beta.-yloxy)hex-3-ynl, oleyl, or hexadecyl are useful immunologic adjuvants in vaccines.